once you start a glp 1 can you stop What Happens When GLP-1: The Data From Three Trials 🥩 Rule #1 on GLP-1?

Clinical trials show ~15% body weight reduction with semaglutide and up to 21% with tirzepatide

Eli Lilly took a similar action in August

2729 This rate is also equivalent to that observed in the reference group with diabetes in our study (2.3%)

Their formulary also generally treats Wegovy as high-tier (Tier 3 or 4) with copays often in the hundreds of dollars ( [20] )

These risks look quite different from those of diabetic patients who already face gastric motility disorders

Semaglutide excels for patients with type 2 diabetes, prediabetes, or cardiovascular risk factors, as it addresses blood sugar control and reduces heart disease risk